MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sorrento Therapeutics Company Profile (NASDAQ:SRNE)

Consensus Ratings for Sorrento Therapeutics (NASDAQ:SRNE) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.33 (39.89% upside)

Analysts' Ratings History for Sorrento Therapeutics (NASDAQ:SRNE)
Show:
DateFirmActionRatingPrice TargetActions
6/30/2015MLV & Co.Reiterated RatingBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015MLV & Co.Reiterated RatingBuy$25.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Brean CapitalInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015HC WainrightReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015HC WainrightBoost Price TargetBuy$13.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014HC WainrightSet Price TargetBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014MLV & Co.Set Price TargetBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014HC WainrightInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2014MLV & Co.Initiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Capital Ideas ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013AegisInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2013CRT CapitalInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/4/2013 forward)